Table 1.
Country | Prevalence of CVID/100,000 | % of CVID of total number of primary immunodeficiencies | Reference |
---|---|---|---|
Denmarka | 3.8 | n.a. | (8) |
Iceland | 3.1 | 17 | (7) |
Norway | 2.6 | 31 | (3) |
Turkey | 1.4 | 5 | (4) |
United Kingdom | 1.3 | 37 | (5) |
Switzerland | 1.2 | 45 | (6) |
France | 0.7 | 14 | (1) |
Spain | 0.6 | 21 | (2) |
CVID, common variable immunodeficiency; n.a., not available.
aIn two Danish regions, the prevalence was 5/100,000.